A citation-based method for searching scientific literature

Benjamin C James, Briseis Aschebrook-Kilfoy, Nicole Cipriani, Edwin L Kaplan, Peter Angelos, Raymon H Grogan. Ann Surg Oncol 2016
Times Cited: 19







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Parathyroid carcinoma: a 43-year outcome and survival analysis.
Avital Harari, Avantika Waring, Gustavo Fernandez-Ranvier, Jimmy Hwang, Insoo Suh, Elliot Mitmaker, Wen Shen, Jessica Gosnell, Quan-Yang Duh, Orlo Clark. J Clin Endocrinol Metab 2011
99
21

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
145
21

Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
Norman G Nicolson, Timothy D Murtha, Weilai Dong, Johan O Paulsson, Jungmin Choi, Andrea L Barbieri, Taylor C Brown, John W Kunstman, Catharina Larsson, Manju L Prasad,[...]. J Clin Endocrinol Metab 2018
33
21

Trends in the incidence and treatment of parathyroid cancer in the United States.
Peter K Lee, Stephanie L Jarosek, Beth A Virnig, Maria Evasovich, Todd M Tuttle. Cancer 2007
146
15

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.
Michal Swierniak, Aleksandra Pfeifer, Tomasz Stokowy, Dagmara Rusinek, Mykola Chekan, Dariusz Lange, Jolanta Krajewska, Małgorzata Oczko-Wojciechowska, Agnieszka Czarniecka, Michal Jarzab,[...]. Mol Cell Endocrinol 2016
21
15

The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
Michiko Fukahori, Akira Yoshida, Hiroyuki Hayashi, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Shiro Koizume, Naoyuki Okamoto, Tetsuo Kondo, Munetake Masuda,[...]. Thyroid 2012
80
15

Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
Briseis Aschebrook-Kilfoy, Mary H Ward, Mona M Sabra, Susan S Devesa. Thyroid 2011
264
15

The changing incidence of thyroid cancer.
Cari M Kitahara, Julie A Sosa. Nat Rev Endocrinol 2016
359
15

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.
Johan O Paulsson, Ninni Mu, Ivan Shabo, Na Wang, Jan Zedenius, Catharina Larsson, C Christofer Juhlin. Endocr Relat Cancer 2018
26
15

Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Lene H S Veiga, Gila Neta, Briseis Aschebrook-Kilfoy, Elaine Ron, Susan S Devesa. Thyroid 2013
69
10

Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.
Claire Sadler, Kenneth W Gow, Elizabeth A Beierle, John J Doski, Monica Langer, Jed G Nuchtern, Sanjeev A Vasudevan, Melanie Goldfarb. Surgery 2014
24
10


Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis.
Michael Schaapveld, Francisca H Jorna, Katja K H Aben, Harm R Haak, John T M Plukker, Thera P Links. Am J Surg 2011
32
10

Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB).
Elliot A Asare, Cord Sturgeon, David J Winchester, Lei Liu, Bryan Palis, Nancy D Perrier, Douglas B Evans, David P Winchester, Tracy S Wang. Ann Surg Oncol 2015
50
10

Is central lymph node dissection necessary for parathyroid carcinoma?
Kun-Tai Hsu, Rebecca S Sippel, Herbert Chen, David F Schneider. Surgery 2014
24
10

Parathyroid carcinoma: update and guidelines for management.
Christina H Wei, Avital Harari. Curr Treat Options Oncol 2012
128
10


Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study.
Jesús Villar-del-Moral, Antonio Jiménez-García, Pilar Salvador-Egea, Juan M Martos-Martínez, José M Nuño-Vázquez-Garza, Mario Serradilla-Martín, Angel Gómez-Palacios, Pablo Moreno-Llorente, Joaquín Ortega-Serrano, Aitor de la Quintana-Basarrate. Surgery 2014
26
10

Carcinoma of endocrine organs: results of the RARECARE project.
Jan Maarten van der Zwan, Sandra Mallone, Boukje van Dijk, Magdalena Bielska-Lasota, Renée Otter, Roberto Foschi, Eric Baudin, Thera P Links. Eur J Cancer 2012
27
10

Parathyroid carcinoma. A study of 70 cases.
A Schantz, B Castleman. Cancer 1973
437
10

Parathyroid Carcinoma: Is It Time for Change?
David F Schneider. Ann Surg Oncol 2015
4
50

Clinical presentation, staging and long-term evolution of parathyroid cancer.
Nadia Talat, Klaus-Martin Schulte. Ann Surg Oncol 2010
65
10

Parathyroid carcinoma: a 22-year experience.
Naifa L Busaidy, Camilo Jimenez, Mouhammed Amir Habra, Pamela N Schultz, Adel K El-Naggar, Gary L Clayman, Joshua A Asper, Eduardo M Diaz, Douglas B Evans, Robert F Gagel,[...]. Head Neck 2004
138
10

Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.
Sherita H Golden, Karen A Robinson, Ian Saldanha, Blair Anton, Paul W Ladenson. J Clin Endocrinol Metab 2009
277
10

Outcomes of adrenal cortical carcinoma in the United States.
B Lauren Paton, Yuri W Novitsky, Marc Zerey, Andrew G Harrell, H James Norton, Horatio Asbun, Kent W Kercher, B Todd Heniford. Surgery 2006
67
10

American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.
Martha A Zeiger, Geoffrey B Thompson, Quan-Yang Duh, Amir H Hamrahian, Peter Angelos, Dina Elaraj, Elliott Fishman, Julia Kharlip. Endocr Pract 2009
194
10

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Marina N Nikiforova, Paul W Biddinger, Christy M Caudill, Todd G Kroll, Yuri E Nikiforov. Am J Surg Pathol 2002
234
10

The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.
Damian Szklarczyk, John H Morris, Helen Cook, Michael Kuhn, Stefan Wyder, Milan Simonovic, Alberto Santos, Nadezhda T Doncheva, Alexander Roth, Peer Bork,[...]. Nucleic Acids Res 2017
10

Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.
Xiaoyu Chen, Ole Schulz-Trieglaff, Richard Shaw, Bret Barnes, Felix Schlesinger, Morten Källberg, Anthony J Cox, Semyon Kruglyak, Christopher T Saunders. Bioinformatics 2016
498
10

Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
Seung-Hyun Jung, Min Sung Kim, Chan Kwon Jung, Hyun-Chun Park, So Youn Kim, Jieying Liu, Ja-Seong Bae, Sung Hak Lee, Tae-Min Kim, Sug Hyung Lee,[...]. Oncotarget 2016
53
10

Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?
Nicole A Cipriani, Sapna Nagar, Sharone P Kaplan, Michael G White, Tatjana Antic, Peter M Sadow, Briseis Aschebrook-Kilfoy, Peter Angelos, Edwin L Kaplan, Raymon H Grogan. Thyroid 2015
29
10

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Ginesa Garcia-Rostan, Hongyu Zhao, Robert L Camp, Marina Pollan, Agustin Herrero, Javier Pardo, Ran Wu, Maria Luisa Carcangiu, Jose Costa, Giovanni Tallini. J Clin Oncol 2003
261
10

Follicular thyroid carcinoma: histology and prognosis.
Alessandra D'Avanzo, Patrick Treseler, Philip H G Ituarte, Mariwil Wong, Leanne Streja, Francis S Greenspan, Allan E Siperstein, Quan-Yang Duh, Orlo H Clark. Cancer 2004
135
10

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
John W Kunstman, C Christofer Juhlin, Gerald Goh, Taylor C Brown, Adam Stenman, James M Healy, Jill C Rubinstein, Murim Choi, Nimrod Kiss, Carol Nelson-Williams,[...]. Hum Mol Genet 2015
181
10

Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
Huy Gia Vuong, Tetsuo Kondo, Naoki Oishi, Tadao Nakazawa, Kunio Mochizuki, Tomohiro Inoue, Ippei Tahara, Kazunari Kasai, Mitsuyoshi Hirokawa, Thong Minh Tran,[...]. Cancer Med 2016
22
10

Follicular thyroid cancer incidence patterns in the United States, 1980-2009.
Briseis Aschebrook-Kilfoy, Raymon H Grogan, Mary H Ward, Edwin Kaplan, Susan S Devesa. Thyroid 2013
70
10

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
10

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.
Iñigo Landa, Nikita Pozdeyev, Christopher Korch, Laura A Marlow, Robert C Smallridge, John A Copland, Ying C Henderson, Stephen Y Lai, Gary L Clayman, Naoyoshi Onoda,[...]. Clin Cancer Res 2019
39
10

PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
C J Guigon, L Zhao, M C Willingham, S-Y Cheng. Oncogene 2009
72
10

Allele-specific copy number analysis of tumors.
Peter Van Loo, Silje H Nordgard, Ole Christian Lingjærde, Hege G Russnes, Inga H Rye, Wei Sun, Victor J Weigman, Peter Marynen, Anders Zetterberg, Bjørn Naume,[...]. Proc Natl Acad Sci U S A 2010
581
10

Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.
Michael Carlberg, Lena Hedendahl, Mikko Ahonen, Tarmo Koppel, Lennart Hardell. BMC Cancer 2016
28
10

Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reports.
Jose Mauricio Mota, Luana Guimarães Sousa, Maria Ignez Braghiroli, Luiz Tenório Siqueira, João Evangelista Bezerra Neto, Paulo Chapchap, Ana A de Oliveira Hoff, Paulo M Hoff. Medicine (Baltimore) 2018
14
14

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma.
Mouhammed Amir Habra, Bettzy Stephen, Matthew Campbell, Kenneth Hess, Coya Tapia, Mingxuan Xu, Jordi Rodon Ahnert, Camilo Jimenez, Jeffrey E Lee, Nancy D Perrier,[...]. J Immunother Cancer 2019
39
10

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.
Martin Fassnacht, Sarah Johanssen, Marcus Quinkler, Peter Bucsky, Holger S Willenberg, Felix Beuschlein, Massimo Terzolo, Hans-Helge Mueller, Stefanie Hahner, Bruno Allolio. Cancer 2009
400
10

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
472
10

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
273
10

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
10

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
10

High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
N R Lemoine, E S Mayall, F S Wyllie, E D Williams, M Goyns, B Stringer, D Wynford-Thomas. Oncogene 1989
413
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.